REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA)
Mexico·Clase I·III. Agentes de diagnóstico·BECKMAN COULTER
DE MÉXICO, S.A. DE
C.V.·Registered July 20, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- EMIT® II PLUS COCAINE METABOLITE ASSAY
- Trade Name (English)
- EMIT® II PLUS COCAINE METABOLITE ASSAY
- Analysis ID
- 0638R2022 SSA
- Registration Date
- July 20, 2022
- Name (Spanish)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA) (REACTIVO PARA DETERMINACIÓN DE BENZOILECGONINA (METABOLITO DE COCAÍNA)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0638R2022 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on July 20, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.